Creative Planning’s Array Biopharma Inc ARRY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-49,508
| Closed | -$2.29M | – | 1990 |
|
|
2019
Q2 | $2.29M | Buy |
49,508
+15,614
| +46% | +$723K | 0.01% | 459 |
|
|
2019
Q1 | $826K | Buy |
33,894
+300
| +0.9% | +$7.31K | ﹤0.01% | 798 |
|
|
2018
Q4 | $479K | Buy |
33,594
+200
| +0.6% | +$2.85K | ﹤0.01% | 979 |
|
|
2018
Q3 | $508K | Sell |
33,394
-306
| -0.9% | -$4.66K | ﹤0.01% | 1060 |
|
|
2018
Q2 | $565K | Buy |
33,700
+1,812
| +6% | +$30.4K | ﹤0.01% | 1000 |
|
|
2018
Q1 | $520K | Buy |
31,888
+9,588
| +43% | +$156K | ﹤0.01% | 1051 |
|
|
2017
Q4 | $285K | Sell |
22,300
-200
| -0.9% | -$2.56K | ﹤0.01% | 1384 |
|
|
2017
Q3 | $277K | Sell |
22,500
-3,300
| -13% | -$40.6K | ﹤0.01% | 1364 |
|
|
2017
Q2 | $216K | Buy |
25,800
+22,500
| +682% | +$188K | ﹤0.01% | 1466 |
|
|
2017
Q1 | $30K | Sell |
3,300
-1,500
| -31% | -$13.6K | ﹤0.01% | 2824 |
|
|
2016
Q4 | $42K | Buy |
4,800
+600
| +14% | +$5.25K | ﹤0.01% | 2521 |
|
|
2016
Q3 | $28K | Sell |
4,200
-200
| -5% | -$1.33K | ﹤0.01% | 2785 |
|
|
2016
Q2 | $16K | Sell |
4,400
-81,899
| -95% | -$298K | ﹤0.01% | 2928 |
|
|
2016
Q1 | $255K | Sell |
86,299
-32,000
| -27% | -$94.6K | ﹤0.01% | 1093 |
|
|
2015
Q4 | $499K | Sell |
118,299
-6,101
| -5% | -$25.7K | ﹤0.01% | 750 |
|
|
2015
Q3 | $567K | Buy |
124,400
+2,000
| +2% | +$9.12K | 0.01% | 688 |
|
|
2015
Q2 | $883K | Buy |
122,400
+120,000
| +5,000% | +$866K | 0.01% | 505 |
|
|
2015
Q1 | $18K | Sell |
2,400
-2,000
| -45% | -$15K | ﹤0.01% | 2790 |
|
|
2014
Q4 | $21K | Buy |
4,400
+2,600
| +144% | +$12.4K | ﹤0.01% | 2597 |
|
|
2014
Q3 | $6K | Buy |
1,800
+1,000
| +125% | +$3.33K | ﹤0.01% | 3177 |
|
|
2014
Q2 | $4K | Hold |
800
| – | – | ﹤0.01% | 3253 |
|
|
2014
Q1 | $4K | Hold |
800
| – | – | ﹤0.01% | 3133 |
|
|
2013
Q4 | $4K | Hold |
800
| – | – | ﹤0.01% | 2949 |
|
|
2013
Q3 | $5K | Hold |
800
| – | – | ﹤0.01% | 2758 |
|
|
2013
Q2 | $4K | Buy |
+800
| New | +$4K | ﹤0.01% | 2648 |
|